Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenue	$ 0	$ 0
Operating expenses:
Research and development	3,054	3,463
General and administrative	2,555	3,742
Total operating expenses	5,609	7,205
Loss from operations	(5,609)	(7,205)
Other income, net	108	92
Net loss	$ (5,501)	$ (7,113)
Net loss per share - basic	$ (0.25)	$ (0.86)
Net loss per share - diluted	$ (0.25)	$ (0.86)
Weighted average common shares outstanding - basic	21,915,891	8,301,798
Weighted average common shares outstanding - diluted	21,915,891	8,301,798
Comprehensive loss:
Net loss	$ (5,501)	$ (7,113)
Other comprehensive gain:
Unrealized gain on investments, net of tax of $0	(45)	0
Foreign currency translation adjustments	31	0
Total other comprehensive gain	(14)	(0)
Total comprehensive loss	$ (5,515)	$ (7,113)